Oncology is changing: the challenge of effectively assessing response within clinical trials in low-grade gliomas
The current WHO classification of primary central nervous system (CNS) tumors recognizes four separate tumor grades (I-IV), which can be grouped into low-grade (I and II) or high-grade (III and IV), depending on the absence or presence of high-grade histopathological features, such as microvascular...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Frontiers Media S.A.,
2011-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The current WHO classification of primary central nervous system (CNS) tumors recognizes four separate tumor grades (I-IV), which can be grouped into low-grade (I and II) or high-grade (III and IV), depending on the absence or presence of high-grade histopathological features, such as microvascular proliferation and necrosis... |
|---|---|
| Item Description: | 10.4081/oncol.2011.75 1970-5557 1970-5565 |